Hughes Hubbard & Reed LLP represented ANI Pharmaceuticals in the transaction. ANI Pharmaceuticals signed an agreement to acquire Novitium Pharma for $89.5 million in cash and $74 million...
This content is for Standard 1 Year members only. LoginJoin Now